Private Equity Firm Healthcare

Vesey Street Capital Partners

New York, New York, United States

Private Equity Partner of Choice for Lower Middle-Market Healthcare Services Companies. Vesey Street Capital Partners (VSCP) is a New York City-based private equity firm specializing in buyouts of lower middle-market healthcare services businesses. Established in 2014, VSCP targets founder-led businesses and corporate carve-outs with robust cash flow and minimal reimbursement risk.

Focus Areas
Healthcare Services, Healthcare Provider, Healthcare Services buyouts
Website
www.vscpllc.com

Tracked deals

7

7 tracked deals across 2019-2026.

Recent pace

1

1 tracked deal announced in the last 12 months.

Deal mix

Recapitalization

4 recapitalization · 2 buyout · 1 addon

Vesey Street Capital Partners Acquisition Volume by Year

Last 6 years

Acquisition volume by year Annual acquisition counts for the last 6 years for Vesey Street Capital Partners. 1 2019 1 2020 1 2021 2 2024 1 2025 ~1 est. 1 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

  • Buyer
    Inceptua Group, Vesey Street Capital Partners
    Target
    SupplyRx, Inc.
    Type
    Buyout

    Inceptua Group, backed by Vesey Street Capital Partners, announced it has acquired SupplyRx, a U.S.-based technology-driven provider of cloud-based digital solutions for clinical trial pharmacy programs in the U.S. and Canada. The acquisition is intended to strengthen Inceptua’s pharmacy model by adding SupplyRx’s portal technology, networks, and processes to improve the clinical supply chain and patient access.

  • Buyer
    Vesey Street Capital Partners
    Target
    ComplexCare Solutions
    Seller
    Inovalon
    Type
    Buyout

    Vesey Street Capital Partners (VSCP) has completed the corporate carveout acquisition of ComplexCare Solutions (CCS) from Inovalon. VSCP will operate CCS as its inaugural platform investment from Healthcare Fund II to expand payor services capabilities and drive growth across health plan customers in the United States.

  • Buyer
    Safecor Health, Vesey Street Capital Partners
    Target
    Viatris' U.S. unit‑dose packaging business (Unit Dose Laboratories / UDL)
    Seller
    Viatris Inc.
    Type
    Addon

    Safecor Health has agreed to acquire the U.S. unit‑dose packaging business of Viatris Inc., formerly known as Unit Dose Laboratories (UDL). The deal, expected to close in the first half of 2025, adds UDL's Rockford, Illinois operations and experienced leadership team to Safecor's portfolio and expands its selection of generic unit‑dose medicines and packaging capabilities; Safecor is a portfolio company of Vesey Street Capital Partners.

  • Buyer
    Vesey Street Capital Partners
    Target
    Inceptua Group
    Location
    Luxembourg

    Vesey Street Capital Partners has completed a majority recapitalization of Luxembourg-headquartered Inceptua Group, a global pharmaceutical services provider specializing in clinical trial supplies and early access programs. As part of the transaction, industry veteran Doug Cook will join Inceptua as Executive Chairman to support the company's capability expansion and growth initiatives alongside CEO Stefan Fraenkel and founder Peter Krantz.

  • Buyer
    Vesey Street Capital Partners, LLC
    Target
    Safecor Health

    Funds managed by Vesey Street Capital Partners completed a recapitalization of Safecor Health, the national leader in pharmaceutical unit-dose packaging services for hospitals, health systems, manufacturers and digital pharmacy companies. The recapitalization (terms undisclosed) is intended to support Safecor's growth, investment in capabilities and expansion via add-on acquisitions; JP Morgan provided debt financing.

  • Buyer
    Vesey Street Capital Partners, LLC
    Target
    QualityMetric

    Vesey Street Capital Partners completed a recapitalization of QualityMetric, a provider of patient-reported outcome (PRO) surveys, enabling technology and health outcomes analytics. VSCP funds provided equity while First Eagle Alternative Credit and Morgan Stanley Credit Partners provided debt financing to support QualityMetric’s next phase of growth; terms were not disclosed.

  • Buyer
    Vesey Street Capital Partners (VSCP)
    Target
    Elite Body Sculpture

    Funds managed by Vesey Street Capital Partners (VSCP) completed a recapitalization of Elite Body Sculpture, a Miami-based provider of minimally invasive body sculpting using the proprietary AirSculpt technology. VSCP and affiliates provided equity (with founder Dr. Aaron Rollins rolling equity), while THL Credit and Morgan Stanley Credit Partners provided debt financing to support the transaction.

Related Acquisition Pages

Selling a company? Get in front of buyers like Vesey Street Capital Partners

Turn tracked acquisition activity into an outreach-ready buyer list.